Skip to content
Home/Companies/MedTech/Avedro
AV

Avedro

MedTech·US·Exited 2019·Held 5yr

Avedro is a MedTech company, headquartered in US.

Entry
2014
Hold
5yr
Exit
2019
Est. EV
–

Who owns Avedro?

Avedro was owned by Abingworth through Abingworth Bioventures VI (2014 vintage) from 2014 to 2019, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-05-21

Abingworth
Investor
Abingworth
Abingworth Bioventures VI · 2014 · Life Sciences VC

Key facts

HQUS
SectorMedTech
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2019

More from Abingworth Bioventures VI

Other portfolio companies in the same fund.

Venatorx Pharmaceuticals
Active
HealthcareUS· 2022
Exicure
Active
BiotechUS· 2019
Soleno Therapeutics
Exited 2026
BiotechUS· 2018
to
Tizona Therapeutics
Active
BiotechUS· 2016
Median Technologies
Active
HealthcareFrance· 2015
GenSight Biologics
Exited 2016
BiotechFrance· 2014

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Aflo
Active
Clarendon Fund ManagersUnited Kingdom
Lattice Medical
Active
Finovam GestionFrance
QTAS
Active
OVNI CapitalGermany
Axomove
Active
Go CapitalFrance· 2026
Bioliberty
Active
Scottish National Investment BankUK· 2026
CertHub
Active
Cusp Capital PartnersGermany· 2026
Data refreshed weekly · Sourced from public filings